دورية أكاديمية

Assessing the Burden of Adverse Events in a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia (CLL)

التفاصيل البيبلوغرافية
العنوان: Assessing the Burden of Adverse Events in a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia (CLL)
المؤلفون: Seymour, John F., Byrd, John C., Munir, Talha *, Ghia, Paolo, Kater, Arnon P., Chanan-Khan, Asher, Furman, Richard R., O'Brien, Susan, Brown, Jennifer R., Mato, Anthony R., Stilgenbauer, Stephan, Fehn, Thomas *, de Miranda, Paulo Andre P., Higgins, Kara *, John, Ellie *, de Borja, Marianne *, Jurczak, Wojciech, Woyach, Jennifer A.
المصدر: In Blood 15 November 2022 140 Supplement 1:7050-7052
قاعدة البيانات: ScienceDirect
الوصف
تدمد:00064971
DOI:10.1182/blood-2022-157060